OR4C49P

Across TCGA pan-cancer cohorts, OR4C49P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated OR4C49P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR4C49P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4C49P expression acts as an unfavorable survival marker, although some lineages such as ESCA and HNSC show a favorable association.

STAD, MESO, and LUSC are the cancer types where OR4C49P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.272	0.740	<.001	78	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	45	view →
GBM	OS	Tertile	All	0.024	0.416	<.001	36	view →
PCPG	OS	Tertile	All	0.524	0.975	<.001	36	view →
LIHC	OS	Tertile	All	0.118	0.783	<.001	27	view →
BLCA	OS	Tertile	All	0.144	0.452	.015	24	view →
SARC	DFS	Tertile	All	0.233	0.532	<.001	24	view →
UCEC	OS	Tertile	All	0.880	0.928	.025	24	view →
ESCA	OS	Tertile	III,IV	0.875	0.359	.018	18	view →
LAML	DFS	Tertile	All	0.153	0.589	.005	18	view →
THCA	DFS	Tertile	All	0.040	0.828	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

OR4C49P–STAD (DFS)

Open the STAD breakdown →